[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336860-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336860-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","correlation-of-the-treatment-sensitivity-of-patient-derived-organoids-with-treatment-outcomes-in-patients-with-head-and-neck-cancer-soto-protocol-for-a-prospective-observational-study","Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO) - protocol for a prospective observational study","","Organoids are used in cancer research because they preserve key features of original tumor tissue, including mutation signatures, phenotype, and genetic diversity, making them promising for translational studies. This protocol aims to determine whether patient-derived organoids can be generated from head and neck squamous cell carcinoma samples and whether organoid-based measures predict treatment sensitivity and clinical outcomes in patients. It also explores potential biomarkers via organoid assays and analysis of circulating tumor DNA and immune profiles from longitudinal biospecimens.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/correlation-of-the-treatment-sensitivity-of-patient-derived-organoids-with-treatment-outcomes-in-patients-with-head-and-neck-cancer-soto-protocol-for-a-prospective-observational-study/336860/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/correlation-of-the-treatment-sensitivity-of-patient-derived-organoids-with-treatment-outcomes-in-patients-with-head-and-neck-cancer-soto-protocol-for-a-prospective-observational-study/336860.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary goal of the SOTO study?","Question",{"text":63,"@type":64},"The study aims to assess whether patient-derived organoids (PDOs) can be generated from head and neck squamous cell carcinoma and whether PDOs can predict treatment sensitivity and treatment outcomes, while exploring potential biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How will participants be grouped in this prospective observational study?",{"text":68,"@type":64},"Patients with HNSCC receiving curative treatment or with recurrent/metastatic disease will be assigned to three cohorts: cohort 1 for primary surgery, cohort 2 for primary radiotherapy, and cohort 3 for recurrent/metastatic disease.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biospecimens are collected and what analyses will be performed?",{"text":72,"@type":64},"Tumor samples are processed into PDOs for chemosensitivity/radiosensitivity testing. Blood and other samples such as saliva are collected at different time intervals for circulating tumor DNA analysis, and PBMCs are stored to assess peripheral immune characteristics and enable co-culture experiments with PDOs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336860,1790435583,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Open access Protocol  \n Correlation of the treatment sensitivity  \nof patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study  \nIfigenia Vasiliadou  ,1 Christiana Cattaneo,1 Phoebe Yuen Ka Chan,1 Rhonda Henley-Smith,2 Harry Gregson-Williams,2 Lisette Collins,2 Gabriella Wojewodka  ,3 Teresa Guerrero-Urbano,4 Jean-Pierre Jeannon,5 Steve Connor,6 Jessica Davis,1 Anna Pasto,1 Rami Mustapha,1 Tony Ng,1 Anthony Kong  1  \nTo cite: Vasiliadou I, Cattaneo C, Chan PYK, et al. Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO):  \nprotocol for a prospective observational study. BMJ Open 2024;14:e084176 . doi:10 . 1136/ bmjopen-2024-084176  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2024-084176](bmjopen-2024-084176)) .  \nReceived 11 January 2024 Accepted 19 August 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Anthony Kong;  \n[anthony.kong@kcl.ac.uk](anthony.kong@kcl.ac.uk)  \nABSTRACT  \nIntroduction Organoids have been successfully used in several areas of cancer research and large living biobanks of patient-derived organoids (PDOs) have been developed from various malignancies. The characteristics of the original tumour tissue such as mutation signatures, phenotype and genetic diversity are well preserved in organoids, thus showing promising results for the use of this model in translational research. In this study, we aim to assess whether we can generate PDOs from head and neck squamous cell carcinoma (HNSCC) samples and whether PDOs can be used to predict treatment sensitivity in HNSCC patients as well as to explore potential biomarkers.  \nMethods and analysis This is a prospective observational study at a single centre (Guy’s and St Thomas’ NHS Foundation Trust) to generate PDOs from patients’ samples to assess treatment response and to correlate with patients’ treatment outcomes. Patients will be included if they are diagnosed with HNSCC undergoing curative treatment (primary surgery or radiotherapy) or presenting with recurrent or metastatic cancers and they will be categorised into three groups (cohort 1:  \nprimary surgery, cohort 2: primary radiotherapy and cohort 3: recurrent/metastatic disease) . Research tumour samples will be collected and processed into PDOs and chemosensitivity/radiosensitivity will be assessed using established methods. Moreover, blood and other biological samples (eg, saliva) will be collected at different time intervals during treatment and will be processed in the laboratory for plasma and peripheral blood mononuclear cell (PBMC) isolation. Plasma and saliva will be used for circulating tumour DNA analysis and PBMC will be stored for assessment of the peripheral immune characteristics of the patients as well as to perform co-culture experiments with PDOs. SOTO study (correlation of the treatment Sensitivity of patient-derived Organoids with Treatment Outcomes in patients with head and neck cancer) uses the collaboration of several specialties in head and neck cancer and has the potential to explore multiple areas  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ A prospective study to generate a living biobank of head and neck squamous cell carcinoma patientderived organoids and treatment sensitivity of organoids can be correlated with clinical outcome of patients.  \n⇒ Allows collection of patients’ fresh tissue and other biological samples at different time points in a prospective manner as well as access to archival samples for translational research.  \n⇒ Allows c","cbCaibdVJxtCW9rf","https://ap.wps.com/l/cbCaibdVJxtCW9rf","pdf",681243,"English","# Abstract\n## Introduction\n## Methods and analysis\n## Strengths and limitations of this study\n## Ethics and dissemination\n## Trial registration number\n# Introduction\n## Head and neck cancer\n## Open access","[{\"question\":\"What is the primary goal of the SOTO study?\",\"answer\":\"The study aims to assess whether patient-derived organoids (PDOs) can be generated from head and neck squamous cell carcinoma and whether PDOs can predict treatment sensitivity and treatment outcomes, while exploring potential biomarkers.\"},{\"question\":\"How will participants be grouped in this prospective observational study?\",\"answer\":\"Patients with HNSCC receiving curative treatment or with recurrent/metastatic disease will be assigned to three cohorts: cohort 1 for primary surgery, cohort 2 for primary radiotherapy, and cohort 3 for recurrent/metastatic disease.\"},{\"question\":\"Which biospecimens are collected and what analyses will be performed?\",\"answer\":\"Tumor samples are processed into PDOs for chemosensitivity/radiosensitivity testing. Blood and other samples such as saliva are collected at different time intervals for circulating tumor DNA analysis, and PBMCs are stored to assess peripheral immune characteristics and enable co-culture experiments with PDOs.\"}]","Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO) - protocol for a prospective observational study | PDF",1790016889,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/451dfe5f9b8998caa2cbd882d4edee3e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b08d00f4470ebcb127d21722922485b1.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/566c7471559b6453b73944c2ca4ecb54.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/310baa89bfffabe35fe8ae88d3aefc38.webp",980,1306]